Tech Company Financing Transactions
Surf Therapeutics Funding Round
Private investors, SOSV and TMC Venture Fund invested in a Seed funding round for Surf Therapeutics. The round closed on 3/17/2026.
Transaction Overview
Company Name
Announced On
3/17/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1401 Lavaca Street 635
Austin, TX 78701
USA
Austin, TX 78701
USA
Phone
Undisclosed
Website
Email Address
Overview
We are developing a unique non-invasive ultrasound neuromodulation platform for treatment of chronic inflammatory disorders by stimulating the spleen-brain axis called the cholinergic anti-inflammatory pathway that helps in controling inflammation. We are transforming how inflammatory disorders are treated. Through precise, non-invasive ultrasound stimulation, our technology restores immune balance safely and naturally from the comfort of home. We are building a future where managing chronic inflammation no longer depends on drugs, but on the body's inherent capacity to heal itself.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nishant Doctor
Chief Marketing Officer
Alex Sackeim
Browse more venture capital transactions:
Prev: 3/17/2026: Upvest venture capital transaction
Next: 3/17/2026: Mestag Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs